Table 3 Distribution of patients over different KDIGO serum creatinine and urine output acute kidney injury stages maximally reached within indicated observation periods
Time window | Maximum AKI stage Number (%) | UO 0a | UO 1a | UO 2a | UO 3a | Total in row |
|---|---|---|---|---|---|---|
12 h | SCr 0a | 140 (77) | â–‘ 11 (6) | â–’ 2 (1) | â–“ 0 (0) | 153 (85) |
24 h | 122 (67) | â–‘ 19 (10) | â–’ 4 (2) | â–“ 0 (0) | 145 (80) | |
7 days | 95 (52) | â–‘ 23 (13) | â–’ 2 (1) | â–“ 0 (0) | 120 (66) | |
12 h | SCr 1a | â–‘ 21 (12) | â–‘ 3 (2) | â–’ 0 (0) | â–“ 0 (0) | 24 (13) |
24 h | â–‘ 27 (15) | â–‘ 4 (2) | â–’ 0 (0) | â–“ 0 (0) | 31 (17) | |
7 days | â–‘ 35 (19) | â–‘ 7 (4) | â–’ 3 (2) | â–“ 0 (0) | 45 (25) | |
12 h | SCr 2a | â–’ 1 (1) | â–’ 1 (1) | â–’ 0 (0) | â–“ 0 (0) | 2 (1) |
24 h | â–’ 0 (0) | â–’ 2 (1) | â–’ 0 (0) | â–“ 0 (0) | 2 (1) | |
7 days | â–’ 4 (2) | â–’ 4 (2) | â–’ 3 (2) | â–“ 0 (0) | 11 (6) | |
12 h | SCr 3a | â–“ 1 (1) | â–“ 1 (1) | â–“ 0 (0) | â–“ 0 (0) | 2 (1) |
24 h | â–“ 2 (1) | â–“ 1 (1) | â–“ 0 (0) | â–“ 0 (0) | 3 (2) | |
7 days | â–“ 4 (2) | â–“ 1 (1) | â–“ 0 (0) | â–“ 0 (0) | 5 (3) | |
12 h | Total in column | 163 (90) | 16 (9) | 2 (1) | 0 (0) | 181 (100) |
24 h | 151 (83) | 26 (14) | 4 (2) | 0 (0) | 181 (100) | |
7 days | 138 (76) | 35 (19) | 8 (4) | 0 (0) | 181 (100) |